Roswell Park Cancer Institute has announced the development of a new cancer vaccine to prevent cancer relapse and eradicate cancer cells.
Officials from Roswell were on hand to highlight what the vaccine can do. They say the NY-ESO-1 dendritic cell vaccine has the potential to "eradicate cancer cells and prevent disease relapse."
The new NY-ESO-1 dendritic cell vaccine is expected to show great promise in patients with bladder, brain, breast, esophageal, gastrointestinal, hepatocellular, kidney, lung, melanoma, ovarian, prostate, sarcoma and uterine tumors.
Not only will the vaccine be administered here in Buffalo, but it will also be manufactured here. Doctors say the development of the vaccine is very encouraging and it has minimal side effects.
Comments